This compound is a fluorinated derivative of prasugrel, used as an intermediate in the synthesis of pharmaceutical products. Its structure includes a thienopyridine ring system and a cyclopropyl carbonyl group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1391194-39-0
4-Fluoro prasugrel
pharmaceutical intermediate
Prasugrel
platelet aggregation inhibitor
Prasugrel hydrochloride
pharmaceutical raw material
Folic Acid EP Impurity F
pharmaceutical intermediate
4-(2-hydroxyethyl)indolin-2-one
pharmaceutical intermediate
(2R,3R)-3-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-2-hydroxy-4-phenylbutanoic acid
pharmaceutical intermediate
(2R,4S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-(((dimethylamino)methylene)amino)-6-oxo-1H-purin-9(6H)-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
pharmaceutical intermediate
(+/-)-Prasugrel-d3 (acetate-d3)
pharmaceutical raw material
[5-[2-cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate
IMTFHRNDRHBYGI-UHFFFAOYSA-N
CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC(=CC=C3)F)C(=O)C4CC4